Health care stocks were steady to higher premarket Wednesday, with The Health Care Select Sector SPDR Fund (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) unchanged.
HealthEquity (HQY) shares were down 15% after the company reported overnight fiscal Q4 non-GAAP earnings that trailed analysts' estimates.
Hutchmed (HCM) and Innovent Biologics said late Tuesday that a phase II/III clinical trial of fruquintinib in combination with sintilimab as a second-line treatment for renal cell carcinoma in China met its primary endpoint of progression free survival. Hutchmed stock was 3.2% higher pre-bell Wednesday.
Concentra (CON) shares were up 3.6% after the company said overnight it opened a new medical center in Waukegan, Illinois.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.